Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Reference Laboratories Announces Signing of Letter of Intent with General Prescription Programs to Form Medical Management Company.


ELMWOOD PARK, NJ--(BUSINESS WIRE)--July 14, 1999--

Bio-Reference Laboratories, Inc. (Nasdaq Small Cap/BRLI), the largest independent clinical testing laboratory in the Northeastern United States, announced the signing of a letter of intent with General Prescription Programs, Inc., a prescription benefit manager ("GPP GPP Government Performance Project
GPP General Purpose Processor
GPP General Physical Preparedness
GPP Gambian People's Party
GPP Good Pharmacy Practice
GPP Gross Primary Productivity
GPP Green Procurement Program
GPP Generic Packetized Protocol
") and others, to form a new company to provide medical management and medical claims processing services to third-party payers of health related claims and benefits. The new company, which will be 80% owned and principally funded by BRLI BRLI Bio Rad Laboratories Inc , is expected to obtain a license to market medical management services to GPP customers representing approximately one million lives. The license will also provide the new company with access to GPP's claims information and analytical software. The proposed transaction is subject to and contingent upon completion of negotiations and preparation and execution of the required agreements.

BRLI also announced today its execution of an employment contract with Dolores Dolores (or Delores) was a common given name (until the 1960s in the USA); it is cognate with the English word "dolorous" (meaning sorrowful) and equivalent in meaning.  Bowman to serve as vice president and director of medical management services. Ms. Bowman most recently served as Vice President of Medical Programs and Services at Sanus Health Plan Corp., a subsidiary of New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 Life NYL NYL Nylon
NYL New York Life
NYL New York Liberty
NYL New York Lottery
NYL National Youth Leadership
NYL MCAS Yuma (airport code) 
 Care Health Plans, Inc., where she was directly responsible for utilization management, claims management and Medical operations.

Dr. Marc Grodman, BRLI's chief executive officer, commented, "For some time, BRLI has been seeking ways to unlock the value in the multitude of transactions we generate. Through the analytical process of interrelating laboratory, prescription and medical claims data, we can provide critical strategies and solutions to promote population health management. This initiative demonstrates our intention of addressing a larger market than defined by laboratory testing alone. The one million lives serviced by GPP may well represent upwards of $3 billion in annual medical expenditures. It is our intent to develop tools to improve the efficiency and quality of the services for which these medical dollars are spent.

We are also pleased to announce the addition of Dolores Bowman to our executive team. Ms. Bowman has an outstanding reputation in the emerging area of population health management. Our association with Ms. Bowman further enhances our expertise in the medical management area."

Bio-Reference Laboratories, Inc. is a highly automated computer-driven clinical laboratory serving specialty markets in the New York/Tri-State metropolitan area. The Company performs highly sophisticated testing procedures in addition to high-volume routing testing in clinical chemistry, special chemistry, endocrinology, serology Serology

The division of biological science concerned with antigen-antibody reactions in serum. It properly encompasses any of these reactions, but is often used in a limited sense to denote laboratory diagnostic tests, especially for syphilis.
, diagnostic immunology, microbiology, rheumatology rheumatology /rheu·ma·tol·o·gy/ (-tol´ah-je) the branch of medicine dealing with rheumatic disorders, their causes, pathology, diagnosis, treatment, etc.

rheu·ma·tol·o·gy
n.
, parasitology Parasitology

The scientific study of parasites and of parasitism. Parasitism is a subdivision of symbiosis and is defined as an intimate association between an organism (parasite) and another, larger species of organism (host) upon which the parasite is
, cellular immunology, radioimmunoassay, hematology, immunohematology, cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. , anatomic pathology and urinalysis.

The Company's common stock is traded on the Nasdaq Small Cap system under the symbol "BRLI."
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 14, 1999
Words:426
Previous Article:OBIT/Gladys Knight's Son Passes Away.
Next Article:Safety Patrols Benefit from Culver's Anniversary.
Topics:



Related Articles
Bio-Reference Labs Announces NDC Health Information Contract for CareEvolve.com.
Bio-Reference Labs Re-Enters Oncology Market; BRLI To Expand GenPath Oncology Cancer Laboratory.
Bio-Reference Laboratories, Inc. Post a Fiscal Profit On Record Revenues; Laboratory Testing Services Continue Growth; Company to Offer New...
Bio-Reference Laboratories Receives Riker's Island - NY - Lab Contract; Extends New York State Prison's Contract; Contracts Valued at Approximately...
Bio-Reference Laboratories Announces 2001 Year-End Earnings Date; Conference Call To Be Broadcast On The Internet.
Bio-Reference Laboratories, Inc. Holds Year-end Analysts' Conference Call; Bio-Reference Joined On Call by CEO of Roche Diagnostics.
Bio-Reference Laboratories, Inc. Announces Date for Second Quarter Earnings and Conference Call.
Bio-Reference CEO, Marc Grodman, M.D., to Speak on Pay-for-Performance; Dr. Grodman Will Present in a Washington G-2 Audio Conference on Wednesday,...
Bio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2006.
Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles